Challenges in reintroducing tuberculosis medications after hepatotoxicity.
Jussi
J
Saukkonen
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy*
D000995:Antitubercular Agents